These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 5560899)

  • 1. Destruction of chlorpromazine during absorption in the rat in vivo and in vitro.
    Curry SH; D'Mello A; Mould GP
    Br J Pharmacol; 1971 Jul; 42(3):403-11. PubMed ID: 5560899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of chlorpromazine in the gastrointestinal tract of the rat and its effect on absorptive function.
    Sundaresan PR; Rivera-Calimlim L
    J Pharmacol Exp Ther; 1975 Sep; 194(3):593-602. PubMed ID: 240020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sucrose absorption by the rat small intestine in vivo and in vitro.
    Davidson RE; Leese HJ
    J Physiol; 1977 May; 267(1):237-48. PubMed ID: 874842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired absorption of chlorpromazine in rats given trihexyphenidyl.
    Rivera-Calimlim L
    Br J Pharmacol; 1976 Mar; 56(3):301-5. PubMed ID: 1260174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat tissue concentrations of chlorimipramine, chlorpromazine and their N-demethylated metabolites after a single oral dose of the parent compounds.
    Sgaragli GP; Valoti M; Palmi M; Frosini M; Giovannini MG; Bianchi L; Della Corte L
    J Pharm Pharmacol; 1995 Sep; 47(9):782-90. PubMed ID: 8583393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine.
    Adamson L; Curry SH; Bridges PK; Firestone AF; Lavin NI; Lewis DM; Watson RD; Xavier CM; Anderson JA
    Dis Nerv Syst; 1973; 34(4):181-91. PubMed ID: 4711886
    [No Abstract]   [Full Text] [Related]  

  • 7. Protein binding of chlorpromazine in vivo and in vitro: effect of chlorpromazine metabolite on chlorpromazine protein binding in rat.
    Sato S; Koshiro A
    Biol Pharm Bull; 1995 Apr; 18(4):586-92. PubMed ID: 7655433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chlorpromazine on L-methionine transport in the rat intestine.
    Sundaresan PR; Rivera-Calimlim L
    Biochem Pharmacol; 1977 Aug; 26(15):1411-5. PubMed ID: 901554
    [No Abstract]   [Full Text] [Related]  

  • 9. The metabolism of chlorpromazine N-oxide in the rat.
    Jaworski TJ; Hawes EM; McKay G; Midha KK
    Xenobiotica; 1988 Dec; 18(12):1439-47. PubMed ID: 3266695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid postabsorptive metabolism of nicotinic acid in rat small intestine may affect transport by metabolic trapping.
    Stein J; Daniel H; Whang E; Wenzel U; Hahn A; Rehner G
    J Nutr; 1994 Jan; 124(1):61-6. PubMed ID: 8283295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 1st communication: absorption and excretion in rats after a single administration of 14C-NS-49.
    Mukai H; Watanabe S; Morino A
    Arzneimittelforschung; 1999 May; 49(5):434-40. PubMed ID: 10367106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlorpromazine metabolism. IX. Pharmacokinetics of chlorpromazine following oral administration in man.
    Whitfield LR; Kaul PN; Clark ML
    J Pharmacokinet Biopharm; 1978 Jun; 6(3):187-96. PubMed ID: 671225
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of chlorimipramine, chlorpromazine and their N-dealkylated metabolites in plasma of healthy volunteers after a single oral dose of the parent compounds.
    Della Corte L; Valoti M; Palmi M; Giovannini MG; Sgaragli GP
    J Pharm Pharmacol; 1993 Sep; 45(9):825-9. PubMed ID: 7903373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorpromazine: concentrations in plasma, excretion in urine and duration of effect.
    Curry SH
    Proc R Soc Med; 1971 Mar; 64(3):285-9. PubMed ID: 5551485
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary excretion of chlorpromazine metabolites following single doses and in steady-state conditions.
    Hollister LE; Curry SH
    Res Commun Chem Pathol Pharmacol; 1971 May; 2(3):330-8. PubMed ID: 4948435
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of chlorpromazine after single and chronic dosage.
    Dahl SG; Strandjord RE
    Clin Pharmacol Ther; 1977 Apr; 21(4):437-48. PubMed ID: 849674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting chlorpromazine plasma levels in psychiatric patients.
    Curry SH; Davis JM; Janowsky DS; Marshall JH
    Arch Gen Psychiatry; 1970 Mar; 22(3):209-15. PubMed ID: 5413268
    [No Abstract]   [Full Text] [Related]  

  • 18. Appearance of monohydroxylated chlorpromazine metabolites in the central nervous system.
    Manian AA; Efron DH; Harris SR
    Life Sci I; 1971 Jun; 10(12):679-84. PubMed ID: 4997439
    [No Abstract]   [Full Text] [Related]  

  • 19. Bioavailability analysis of chlorpromazine in humans from pupilometric data.
    Smolen VF; Murdock HR; Williams EJ
    J Pharmacol Exp Ther; 1975 Dec; 195(3):404-15. PubMed ID: 1195127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.